CRIS

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 2.93 M3.35 M2.38 M2.75 M3.18 M 11.65 M Gross profit 2.93 M3.35 M2.38 M2.75 M3.18 M 11.65 M Operating expenses 3.84 M3.38 M4.06 M3.58 M3.7 M 14.72 M Selling/general/admin expenses 3.75 M3.35 M3.98 M3.53 M3.65 M 14.52 M Research & development 9.72 M8.97 M8.54 M7.46 M6.43 M 31.4 M Operating income 10.57 M8.99 M10.16 M8.25 M6.92 M 34.33 M Non-Operating Income, Total 475 K-624 K459 K342 K805 K 982 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 475 K-624 K459 K342 K805 K 982 K Unusual income/expense ————— — Pretax income 11.04 M8.37 M10.62 M8.59 M7.73 M 35.31 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 10.09 M9.63 M10.6 M8.59 M7.73 M 36.55 M Discontinued operations ————— — Net income 10.09 M9.63 M10.6 M8.59 M7.73 M 36.55 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 10.09 M9.63 M10.6 M8.59 M7.73 M 36.55 M Basic earnings per share (Basic EPS) -1.69-1.1-1.25-0.57-0.26 -3.18 Diluted earnings per share (Diluted EPS) -1.69-1.1-1.25-0.57-0.26 -3.18 Average basic shares outstanding 5.94 M6.31 M8.49 M12.63 M15.68 M 43.11 M Diluted shares outstanding 5.94 M6.31 M8.49 M12.63 M15.68 M 43.11 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 6 000428 K000 428 K